Costs and outcomes of noncardioembolic ischemic stroke in a managed care population

Vascular Health and Risk Management

Volumn 6, Issue 1, 2010, Pages 905-913

  Engel Nitz, Nicole M ^a   Sander, Stephen D ^b   Harley, Carolyn ^c   Rey, Gabriel Gomez ^a   Shah, Hemal ^b  

^a Health Economics and Outcomes Research   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

^c Health Economic and Outcomes Research   (United States)

Author keywords

Burden of illness; Cardiovascular disease; Claims analysis; Costs of care; Health care outcomes; Stroke cerebrovascular accident

Indexed keywords

ADULT; ADVERSE OUTCOME; AGE DISTRIBUTION; AGED; ARTICLE; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; COST OF ILLNESS; FATALITY; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEALTH CARE COST; HIGH RISK POPULATION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; NONCARDIOEMBOLIC ISCHEMIC STROKE; OUTCOME ASSESSMENT; PATIENT IDENTIFICATION; PATIENT SELECTION; RECURRENT DISEASE; RETROSPECTIVE STUDY; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; UNITED STATES; ADOLESCENT; AGE; CHI SQUARE DISTRIBUTION; ECONOMICS; HEALTH INSURANCE; HOSPITALIZATION; KAPLAN MEIER METHOD; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; STROKE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHI-SQUARE DISTRIBUTION; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STROKE; UNITED STATES; YOUNG ADULT;

EID: 79952053325     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S10851     Document Type: Article

References (25)

1. Holloway RG, Benesch CG, Rahilly CR, Courtright CE. A systematic review of cost-effectiveness research of stroke evaluation and treatment. Stroke. 1999;30(7):1340-1349.
2. Evers SM, Ament AJ, Blaauw G. Economic evaluation in stroke research: a systematic review. Stroke. 2000;31(5):1046-1053.
3. Dewey HM, Thrift AG, Mihalopoulos C, et al. Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke. 2001;32(10):2409-2416.
4. Kavanagh S, Knapp M, Patel A. Costs and disability among stroke patients. J Public Health Med. 1999;21(4):385-394.
5. Asplund K, Stegmayr B, Peltonen M. From the twentieth to the twentyfirst century: a public health perspective on stroke. In: Ginsberg MD, Bogousslavsky J, editors. Cerebrovascular Disease Pathophysiology, Diagnosis, and Management. Chapter 64, Vol. 2. Malden (MA): Blackwell Science; 1998:901-918.
6. Lloyd-Jones D, Adams R, Carnethon M, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):e21-e181.
7. Samsa GP, Bian J, Lipscomb J, Matchar DB. Epidemiology of recurrent cerebral infarction: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. Stroke. 1999;30(2): 338-349.
8. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/Northern Kentucky stroke study: preliminary first-ever and total incidence rates of stroke among Blacks. Stroke. 1998;29(2):415-421.
9. Ovbiagele B. The emergency department: first line of defense in preventing secondary stroke. Acad Emerg Med. 2006;13(2):215-222.
10. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Long-term risk of recurrent stroke after a first-ever stroke: the Oxfordshire Community Stroke Project. Stroke. 1994;25(2):333-337.
11. Leira EC, Chang KC, Davis PH, et al. Can we predict early recurrence in acute stroke? Cerebrovasc Dis. 2004;18(2):139-144.
12. Hier DB, Foulkes MA, Swiontoniowski M, et al. Stroke recurrence within 2 years after ischemic infarction. Stroke. 1991;22(2):155-161.
13. Bureau of Labor Statistics, US Department of Labor. Chained consumer price index; 1999. https://www.policyarchive.org. Accessed 2009 Oct 6.
14. Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ. 1998;17(3):283-295.
15. Leibson CL, Hu T, Brown RD, Hass SL, O'Fallon WM, Whisnant JP. Utilization of acute care services in the year before and after first stroke: a population-based study. Neurology. 1996;46(3):861-869.
16. Taylor TN, Davis PH, Torner JC, Holmes J, Meyer JW, Jacobson MF. Lifetime cost of stroke in the United States. Stroke. 1996;27(9): 1459-1466.
17. Diringer MN, Edwards DF, Mattson DT, et al. Predictors of acute hospital costs for treatment of ischemic stroke in an academic center. Stroke. 1999;30(4):724-728.
18. Matz R. Cost-effective, risk-free, evidence-based medicine. Arch Intern Med. 2003;163(8):884-892.
19. Vickery BG, Rector TS, Wickstrom SL, et al. Occurrence of secondary ischemic events among persons with atherosclerotic vascular disease. Stroke. 2002;33(4):901-906.
20. di Pasquale G, Andreoli A, Pinelli G, et al. Cerebral ischemia and asymptomatic coronary artery disease: a prospective study of 83 patients. Stroke. 1986;17(6):1098-1101.
21. Brown DL, Lisabeth LD, Roychoudhury C, Ye Y, Morgenstern LB. Recurrent stroke risk is higher than cardiac event risk after initial stroke/ transient ischemic attack. Stroke. 2005;36(6):1285-1287.
22. Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000;284(22): 2901-2906.
23. Rosamond W, Flegal K, Friday G, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2007;115(5):e69-e171. Erratum in: Circulation. 2007; 115(5):e172.
24. Weinberger J. Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke. Drugs. 2005;65(4): 461-471.
25. Sacco RL, Adams R, Albers G, et al. American Heart Association; American Stroke Association Council on Stroke; Council on Cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke. Co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37(2):577-617.